MOHAMMED AHMED: Open Payments
NPI 1235153396 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 43 payments from 10 companies in 2025. Trend: 2023 $344 · 2024 $621 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $227 |
| Novo Nordisk Inc | 12 | $193 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $58 |
| Abbott Laboratories | 3 | $56 |
| Astellas Pharma US Inc | 2 | $55 |
| Lilly USA, LLC | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
| Antares Pharma, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: TRELEGY ELLIPTA, Ozempic, JARDIANCE, Kerendia, FREESTYLE LIBRE 3, Veozah, MOUNJARO, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
